Randomized Double Blind Placebo Controlled Clinical Trial to Evaluate Obese and Overweight Subjects

NCT04375696 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Weight Loss

Interventions

DRUG: Polyglucosamine L112
OTHER: Placebo

Sponsor

Certmedica International GmbH